Skip to content

Supportive Expressive Therapy for Depressed and Anxious Adolescents

Supportive Expressive Therapy for Depressed and Anxious Adolescents

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00381979
Enrollment
20
Registered
2006-09-28
Start date
2004-01-31
Completion date
2007-10-31
Last updated
2015-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Anxiety

Keywords

Depression, Anxiety, Adolescents, Treatment, Supportive Expressive Therapy

Brief summary

The purpose of the study is to investigate the effectiveness of providing Supportive Expressive Therapy to adolescents who are depressed and/or anxious.

Detailed description

Supportive Expressive Therapy (SET; a 16 session manualized form of psychodynamic therapy) has been well utilized with adult clients. To date, there is no known systematic study into the benefit of this method of therapy with adolescents who are depressed and/or anxious. It is thought that SET would be useful for this population as it is similar in principle to Interpersonal Relationship Therapy (IPT), which has been shown to be effective for use with depressed adults and youth. Both IPT and SET help clients explore the role they play within challenging relationships in their lives. SET, however, allows for the exploration of more relationships within the adolescents' circle. Moreover, SET explores the adolescents' perceptions of themselves, others, and their wish in relationships. Further, the SET method is more easily individualized in that it affords greater flexibility in design and possibility for change over time. Accordingly, the purpose of this study is to explore the feasibility of utilizing this method of therapy with adolescents who are depressed and anxious. We will be exploring the effectiveness of SET through the resolution of depressed and/or anxious adolescents' conflictual relationships thereby reducing their symptomatology.

Interventions

Sponsors

Centre for Addiction and Mental Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to 24 Years
Healthy volunteers
No

Inclusion criteria

* 15-24 year old, male & female adolescents, primary diagnosis of depression or anxiety disorder. * Clients with co-morbid diagnoses, suicidal ideation or taking medication would not necessarily be excluded if deemed able to partake in the proposed therapy. * Medication dose needs to be stable for 4-6 weeks prior to starting therapy.

Exclusion criteria

* Clients who are actively psychotic, developmentally delayed, or have a diagnosis of bipolar disorder. * Clients who are not fluent in English.

Design outcomes

Primary

MeasureTime frame
BDIpre and post
MASCpre and post
Measures collected at pre, post, and follow-uppre and post

Secondary

MeasureTime frame
Measures collected at pre, post, and follow-uppre and post
FAMpre and post
CBCLpre and post
YSRpre and post
CRIpre and post
SSRSpre and post

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026